ctrl K

Price Alert

Eledon Pharmaceuticals In... (ELDN)

NASDAQ: ELDN · Real-Time Price · USD

2.63

0.03 (1.15%)

At close: Aug 15, 2025, 3:59 PM

2.60

-0.95%

After-hours: Aug 15, 2025, 06:10 PM EDT

Eledon Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	20.55M	4.61M	56.41M	84.83M
Short-Term Investments	119.63M	46.49M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	363K	186K	150K	400K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	729K	90K	28K	34K
Total Current Assets	143.73M	56.13M	59.52M	88.35M
Property-Plant & Equipment	926K	365K	739K	768K
Goodwill & Intangibles	32.39M	32.39M	32.39M	81.03M
Total Long-Term Assets	33.67M	32.94M	33.27M	82.2M
Total Assets	177.41M	89.07M	92.79M	170.55M
Account Payables	5.83M	967K	2.2M	1.81M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	314K	n/a	363K	369K
Other Current Liabilities	1.6M	2M	1.64M	1.15M
Total Current Liabilities	11.58M	3.9M	6.47M	4.4M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	44.87M	76.21M	n/a	n/a
Total Long-Term Liabilities	47.69M	77.96M	2.13M	2.15M
Total Liabilities	59.27M	81.86M	8.61M	6.55M
Total Debt	954K	383K	746K	769K
Common Stock	60K	24K	14K	14K
Retained Earnings	-355.59M	-319.4M	-202.87M	-114.9M
Comprehensive Income	26K	n/a	0.00	n/a
Shareholders Equity	118.14M	7.21M	84.18M	164M
Total Investments	119.63M	46.49M	n/a	n/a